IDRA logo

Idera Pharmaceuticals (IDRA) Total Assets

Annual Total Assets

$34.86 M
-$7.54 M-17.77%

December 31, 2021

Summary

Performance

1-Year Change

-17.77%

3-Year Change

-52.26%

5-Year Change

-70.56%

15-Year Change

-70.56%

IDRA Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$118.42 M
IDRA annual total assets is currently -70.56% below its historical high of $118.42 million

3-Year Low

$34.86 M
IDRA annual total assets is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
IDRA previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
IDRA next annual earnings announcement has not yet been scheduled

OtherIDRAbalance sheetmetrics:

Annual Current Assets

$34.04 M
IDRA annual total current assets is $34.04 million

Annual Non Current Assets

$826.00 K
IDRA annual long term assets is $826.00 thousand

Annual Total Liabilities

$5.41 M
IDRA annual total liabilities is $5.41 million

Annual Current Liabilities

$4.86 M
IDRA annual total current liabilities is $4.86 million

Quarterly Total Assets

$103.68 M
+$77.38 M+294.14%

September 30, 2022

Summary

Performance

3-Month Change

+294.14%

1-Year Change

+164.63%

3-Year Change

+128.41%

5-Year Change

+46.55%

IDRA Quarterly Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$120.31 M
IDRA quarterly total assets is currently -13.82% below its historical high of $120.31 million

3-Year Low

$26.31 M
IDRA quarterly total assets is currently +294.14% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
IDRA previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
IDRA next earnings announcement has not yet been scheduled

OtherIDRAbalance sheetmetrics:

Quarterly Current Assets

$30.07 M
IDRA quarterly total current assets is $30.07 million

Quarterly Non Current Assets

$73.61 M
IDRA quarterly long term assets is $73.61 million

Quarterly Total Liabilities

$82.91 M
IDRA quarterly total liabilities is $82.91 million

Quarterly Current Liabilities

$19.23 M
IDRA quarterly total current liabilities is $19.23 million

Total Assets Formula

Total Assets = Current Assets + Non-Current Assets

Annual Total Assets

$34.86 M
IDRA annual total assets is $34.86 million

Annual Non Current Assets

$826.00 K
IDRA annual long term assets is $826.00 thousand

Annual Current Assets

$34.04 M
IDRA annual total current assets is $34.04 million

IDRA Total Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-17.8%+164.6%
3 y3 years-52.3%+128.4%
5 y5 years-70.6%+46.5%

IDRA Total Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat lowat high-74.6%
5 y5-year-26.6%at lowat high-74.6%
alltimeall time-70.6%-71.3%-13.8%-93.4%

Idera Pharmaceuticals Total Assets History

DateAnnualQuarterly
Sep 2022
-
$103.68 M(+294.1%)
Jun 2022
-
$26.31 M(-12.7%)
Mar 2022
-
$30.13 M(-13.6%)
Dec 2021
$34.86 M(-17.8%)
$34.86 M(-11.0%)
Sep 2021
-
$39.18 M(-11.8%)
Jun 2021
-
$44.41 M(-7.5%)
Mar 2021
-
$48.01 M(+13.2%)
Dec 2020
$42.40 M(-10.7%)
$42.40 M(+31.1%)
Sep 2020
-
$32.34 M(-7.0%)
Jun 2020
-
$34.78 M(-6.2%)
Mar 2020
-
$37.07 M(-21.9%)
Dec 2019
$47.49 M(-35.0%)
$47.49 M(+4.6%)
Sep 2019
-
$45.39 M(-16.5%)
Jun 2019
-
$54.33 M(-12.4%)
Mar 2019
-
$62.00 M(-15.1%)
Dec 2018
$73.02 M(-38.3%)
$73.02 M(-14.3%)
Sep 2018
-
$85.23 M(-14.4%)
Jun 2018
-
$99.51 M(-11.0%)
Mar 2018
-
$111.75 M(-5.6%)
Dec 2017
$118.42 M(+4.6%)
$118.42 M(+67.4%)
Sep 2017
-
$70.75 M(-15.1%)
Jun 2017
-
$83.37 M(-14.6%)
Mar 2017
-
$97.57 M(-13.8%)
Dec 2016
$113.23 M(+22.7%)
$113.23 M(+93.6%)
Sep 2016
-
$58.48 M(-15.5%)
Jun 2016
-
$69.24 M(-12.7%)
Mar 2016
-
$79.32 M(-14.0%)
Dec 2015
$92.28 M(+79.4%)
$92.28 M(-6.9%)
Sep 2015
-
$99.08 M(-9.8%)
Jun 2015
-
$109.83 M(-8.7%)
Mar 2015
-
$120.31 M(+133.9%)
Dec 2014
$51.43 M(+39.5%)
$51.43 M(-15.2%)
Sep 2014
-
$60.63 M(-8.9%)
Jun 2014
-
$66.57 M(-7.9%)
Mar 2014
-
$72.24 M(+95.9%)
Dec 2013
$36.87 M(+240.6%)
$36.87 M(-6.8%)
Sep 2013
-
$39.57 M(+133.4%)
Jun 2013
-
$16.96 M(+148.9%)
Mar 2013
-
$6.81 M(-37.0%)
Dec 2012
$10.82 M(-57.7%)
$10.82 M(+19.3%)
Sep 2012
-
$9.07 M(-35.7%)
Jun 2012
-
$14.11 M(-28.1%)
Mar 2012
-
$19.63 M(-23.3%)
Dec 2011
$25.59 M(-30.6%)
$25.59 M(+25.2%)
Sep 2011
-
$20.44 M(-19.4%)
Jun 2011
-
$25.35 M(-17.3%)
Mar 2011
-
$30.65 M(-16.9%)
DateAnnualQuarterly
Dec 2010
$36.88 M(-22.6%)
$36.88 M(-20.0%)
Sep 2010
-
$46.08 M(+26.3%)
Jun 2010
-
$36.49 M(-13.4%)
Mar 2010
-
$42.12 M(-11.6%)
Dec 2009
$47.64 M(-19.8%)
$47.64 M(-4.6%)
Sep 2009
-
$49.96 M(-9.8%)
Jun 2009
-
$55.38 M(+1.8%)
Mar 2009
-
$54.41 M(-8.4%)
Dec 2008
$59.40 M(+114.3%)
$59.40 M(-7.6%)
Sep 2008
-
$64.31 M(+0.9%)
Jun 2008
-
$63.71 M(-3.2%)
Mar 2008
-
$65.82 M(+137.5%)
Dec 2007
$27.71 M(-31.6%)
$27.71 M(-12.4%)
Sep 2007
-
$31.65 M(-11.8%)
Jun 2007
-
$35.89 M(-4.5%)
Mar 2007
-
$37.60 M(-7.3%)
Dec 2006
$40.54 M(+305.8%)
$40.54 M(+334.8%)
Sep 2006
-
$9.32 M(-7.4%)
Jun 2006
-
$10.07 M(-31.8%)
Mar 2006
-
$14.77 M(+47.9%)
Dec 2005
$9.99 M(-35.1%)
$9.99 M(-29.2%)
Sep 2005
-
$14.10 M(-18.2%)
Jun 2005
-
$17.24 M(+43.1%)
Mar 2005
-
$12.05 M(-21.7%)
Dec 2004
$15.39 M(+6.8%)
$15.39 M(-17.0%)
Sep 2004
-
$18.53 M(+7.3%)
Jun 2004
-
$17.27 M(+49.2%)
Mar 2004
-
$11.58 M(-19.6%)
Dec 2003
$14.41 M(-32.2%)
$14.41 M(-22.5%)
Sep 2003
-
$18.59 M(+116.4%)
Jun 2003
-
$8.59 M(-29.2%)
Mar 2003
-
$12.13 M(-42.9%)
Dec 2002
$21.25 M(-34.2%)
$21.25 M(-16.3%)
Sep 2002
-
$25.40 M(-9.1%)
Jun 2002
-
$27.95 M(-9.8%)
Mar 2002
-
$30.97 M(-4.2%)
Dec 2001
$32.31 M(+223.0%)
$32.31 M(+24.9%)
Sep 2001
-
$25.88 M(+12.2%)
Jun 2001
-
$23.05 M(+208.7%)
Mar 2001
-
$7.47 M(-25.3%)
Dec 2000
$10.00 M(-6.5%)
$10.00 M(-12.5%)
Sep 2000
-
$11.43 M(+65.0%)
Jun 2000
-
$6.93 M(-33.9%)
Mar 2000
-
$10.48 M
Dec 1999
$10.70 M(-35.3%)
-
Dec 1998
$16.54 M(-52.9%)
-
Dec 1997
$35.07 M(-15.6%)
-
Dec 1996
$41.54 M
-

FAQ

  • What is Idera Pharmaceuticals annual total assets?
  • What is the all time high annual total assets for Idera Pharmaceuticals?
  • What is Idera Pharmaceuticals annual total assets year-on-year change?
  • What is Idera Pharmaceuticals quarterly total assets?
  • What is the all time high quarterly total assets for Idera Pharmaceuticals?
  • What is Idera Pharmaceuticals quarterly total assets year-on-year change?

What is Idera Pharmaceuticals annual total assets?

The current annual total assets of IDRA is $34.86 M

What is the all time high annual total assets for Idera Pharmaceuticals?

Idera Pharmaceuticals all-time high annual total assets is $118.42 M

What is Idera Pharmaceuticals annual total assets year-on-year change?

Over the past year, IDRA annual total assets has changed by -$7.54 M (-17.77%)

What is Idera Pharmaceuticals quarterly total assets?

The current quarterly total assets of IDRA is $103.68 M

What is the all time high quarterly total assets for Idera Pharmaceuticals?

Idera Pharmaceuticals all-time high quarterly total assets is $120.31 M

What is Idera Pharmaceuticals quarterly total assets year-on-year change?

Over the past year, IDRA quarterly total assets has changed by +$64.50 M (+164.63%)